ICYMI: Multi-objective antibody design and optimization using machine learning
Nature Reviews Bioengineering, Published online: 09 June 2026; doi:10.1038/s44222-026-00444-4Antibodies are among the best-selling drugs and are crucial for numerous therapeutic and diagnostic purposes. However, optimizing antibodies for desirable drug-like properties has long been a hurdle, delaying or preventing promising drugs from reaching patients. Advances in computational methods, especially those using artificial intelligence and machine learning, can streamline and enhance conventional methods, enabling more efficient discovery and optimization of therapeutic antibodies.
